Nigeria experiencing horrific business environment - Atiku worried over GlaxoSmithKline's exit

  • 📰 DailyPostNGR
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 59%

United States News News

United States United States Latest News,United States United States Headlines

Atiku Abubakar, the presidential candidate of the Peoples Democratic Party, PDP, has expressed concern over the planned exit of GlaxoSmithKline from

According to him, the company’s showed how horrific the country is becoming for businesses.

In reaction, Atiku expressed sadness that many international firms are exiting Nigeria due to the harsh economic environment.The former Vice President advised that the government needs to do more to encourage foreign investors. “The planned exit of GlaxoSmithKline from Nigeria after more than five decades of doing business in Nigeria underscores how horrific the environment has become for both local and foreign businesses.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GSK Company, Other Multinationals Are Sadly Leaving Nigeria Over Government’s Poor Economic Management – Peter Obi | Sahara ReportersThe presidential candidate of the Labour Party (LP) in the 2023 general elections, Peter Obi, has blamed the proposed exit of the British pharmaceutical giant, GlaxoSmithKline (GSK) from Nigeria after 51 years on poor economic management by the President Bola Tinubu-led Nigerian government. SaharaReporters on Friday reported that GlaxoSmithKline, GSK Nigeria announced its plan to cease operations in Nigeria after evaluating the options for moving to a third-party distribution model for its drugs and consumer healthcare goods.
Source: SaharaReporters - 🏆 9. / 63 Read more »